BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38291686)

  • 1. Towards a Standardized Classification of the Hepatobiliary Manifestations in Cystic Fibrosis (CFHBI): A Joint ESPGHAN/NASPGHAN Position Paper.
    Bodewes FAJA; Freeman AJ; Weymann A; Debray D; Scheers I; Verkade HJ; Narkewicz MR
    J Pediatr Gastroenterol Nutr; 2024 Jan; 78(1):153-165. PubMed ID: 38291686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
    van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
    Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Algorithm for the Integration of Ultrasound Into Cystic Fibrosis Liver Disease Screening.
    Sellers ZM; Lee LW; Barth RA; Milla C
    J Pediatr Gastroenterol Nutr; 2019 Oct; 69(4):404-410. PubMed ID: 31181020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supersonic shear-wave elastography and APRI for the detection and staging of liver disease in pediatric cystic fibrosis.
    Calvopina DA; Noble C; Weis A; Hartel GF; Ramm LE; Balouch F; Fernandez-Rojo MA; Coleman MA; Lewindon PJ; Ramm GA
    J Cyst Fibros; 2020 May; 19(3):449-454. PubMed ID: 31303380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
    Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis related liver disease and endocrine considerations.
    Sherwood JS; Ullal J; Kutney K; Hughan KS
    J Clin Transl Endocrinol; 2022 Mar; 27():100283. PubMed ID: 35024343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
    Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis.
    Lewindon PJ; Puertolas-Lopez MV; Ramm LE; Noble C; Pereira TN; Wixey JA; Hartel GF; Calvopina DA; Leung DH; Ramm GA
    Clin Gastroenterol Hepatol; 2019 Nov; 17(12):2561-2569.e5. PubMed ID: 30880274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Transient Elastography, ShearWave Elastography, Magnetic Resonance Elastography and FibroTest as routine diagnostic markers for assessing liver fibrosis in children with Cystic Fibrosis.
    Dana J; Girard M; Franchi-Abella S; Berteloot L; Benoit-Cherifi M; Imbert-Bismut F; Sermet-Gaudelus I; Debray D
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101855. PubMed ID: 34933150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives.
    Debray D; Narkewicz MR; Bodewes FAJA; Colombo C; Housset C; de Jonge HR; Jonker JW; Kelly DA; Ling SC; Poynard T; Sogni P; Trauner M; Witters P; Baumann U; Wilschanski M; Verkade HJ
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):443-448. PubMed ID: 28753176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
    Calvopina DA; Chatfield MD; Weis A; Coleman MA; Fernandez-Rojo MA; Noble C; Ramm LE; Leung DH; Lewindon PJ; Ramm GA
    Hepatology; 2018 Dec; 68(6):2301-2316. PubMed ID: 30014495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies.
    Dana J; Debray D; Beaufrère A; Hillaire S; Fabre M; Reinhold C; Baumert TF; Berteloot L; Vilgrain V
    J Hepatol; 2022 Feb; 76(2):420-434. PubMed ID: 34678405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease.
    Karnsakul W; Wasuwanich P; Ingviya T; Vasilescu A; Carson KA; Mogayzel PJ; Schwarz KB
    J Cyst Fibros; 2020 Jul; 19(4):546-552. PubMed ID: 32482593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up and liver outcomes in children with cystic fibrosis and nodular liver on ultrasound in a multi-center study.
    Leung DH; Ye W; Schwarzenberg SJ; Freeman AJ; Palermo JJ; Weymann A; Alonso EM; Karnsakul WW; Murray KF; Stoll JM; Huang S; Karmazyn B; Masand P; Magee JC; Alazraki AL; Towbin AJ; Nicholas JL; Green N; Otto RK; Siegel MJ; Ling SC; Navarro OM; Harned RK; Narkewicz MR; Molleston JP;
    J Cyst Fibros; 2023 Mar; 22(2):248-255. PubMed ID: 35985930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study.
    Dajti E; Ravaioli F; Paiola G; Volpi S; Colecchia L; Ferrarese A; Alemanni LV; Cusumano C; Di Biase AR; Marasco G; Vestito A; Festi D; Rautou PE; Cipolli M; Colecchia A
    Liver Int; 2023 Nov; 43(11):2492-2502. PubMed ID: 37724776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic risk factors for cystic fibrosis-related liver disease in Egyptian CF children: A single-center experience.
    El-Faramawy A; Nasr SZ; Emam MMSA; Fahmy HMH
    Pediatr Pulmonol; 2024 Feb; 59(2):465-471. PubMed ID: 38038166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores.
    Karlas T; Neuschulz M; Oltmanns A; Güttler A; Petroff D; Wirtz H; Mainz JG; Mössner J; Berg T; Tröltzsch M; Keim V; Wiegand J
    PLoS One; 2012; 7(7):e42139. PubMed ID: 22848732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.
    Sadler MD; Crotty P; Fatovich L; Wilson S; Rabin HR; Myers RP
    Can J Gastroenterol Hepatol; 2015 Apr; 29(3):139-44. PubMed ID: 25855877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of noninvasive markers for the diagnosis of cystic fibrosis liver disease.
    Alexopoulou A; Pouriki S; Vasilieva L; Alexopoulos T; Filaditaki V; Gioka M; Diamantea F; Dourakis SP
    Scand J Gastroenterol; 2018 Dec; 53(12):1547-1552. PubMed ID: 30600723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.